
Opinion|Videos|August 14, 2024
Combination Therapies and Intensifications of ADT in Advanced Prostate Cancer
The panel outlines combination therapy options for patients with advanced prostate cancer and discusses the potential benefits of intensification of androgen deprivation therapy.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
3
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
4
Urocross shows sustained benefit through 24 months post-removal
5















